Position in LH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$8,960
+$423 QoQ
Shares Held
32
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#947
of 1,040 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Glen Eagle Advisors, LLC holds $1,870,524 across 10 Diagnostics & Research names. LH ranks #7 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IDXX |
Idexx Laboratories Inc /De
|
1,702 | $896,000 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
854 | $428,161 | |
| 3 | NEO |
Neogenomics Inc
|
19,500 | $284,505 | |
| 4 | WAT |
Waters Corp /De/
|
394 | $147,765 | |
| 5 | DGX |
Quest Diagnostics Inc
|
400 | $84,780 | |
| 6 | DHR |
Danaher Corp /De/
|
76 | $14,476 | |
| 7 | LH |
Labcorp Holdings Inc.
This page
|
32 | $8,960 | |
| 8 | OPK |
Opko Health, Inc.
|
2,100 | $3,150 |
All Filings in LH
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,960 | 32 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $8,537 | 32 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $7,777 | 31 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $8,898 | 31 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $5,250 | 20 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,654 | 20 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4,586 | 20 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $4,469 | 20 | Shares | Sole | 2024-11-15 | |
| No filing history on record for this holder in this stock. | ||||||